News

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.
Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax COVID-19 shot have slumped.
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
SMi are announcing the free webinar, "Prefilled Syringe Elastomer Components High-quality Solutions for Sensitive Molecules" on 16th July 2020.
FDA raised safety concerns for Vyvgart Hytrulo in CIDP, while Argenx moves ARGX-119 into late-stage trials for rare ...
Risk of mislabeled syringes if a drug was withdrawn from a Carpuject cartridge into a prefilled, labeled syringe of diluent (e.g., drug added to a normal saline flush cartridge) ...
All nurses should be re-oriented to use the Carpuject prefilled syringes as intended by the manufacturer, and to ensure understanding of the risks associated with using the cartridges as vials ...
Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...
The prefilled syringe formulation is the first DHE auto-injector that patients can self-administer in a ready-to-use form, according to Amneal. The injector does not require refrigeration ...